Overview
- 85 inspections across 84 sites are on record.
- 398 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-10-27.
At a glance
Inspections
85
Sites
84
Observations
398
Career since
Oct 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shree Jaya Laboratories Private Limited | 27 Oct 2022 | Human Drugs | On file |
| Pfizer Healthcare India Private Limited | 18 Oct 2022 | Human Drugs | On file |
| Novartis Pharma AG | 30 Aug 2022 | Human Drugs | On file |
| Novartis Pharma Schweizerhalle Ag | 25 Aug 2022 | Human Drugs | |
| Novo Nordisk Production Belgium SA | 19 Aug 2022 | Medical Devices & Rad Health | On file |
Sites inspected
Shree Jaya Laboratories Private LimitedNalgonda, India1 insp.
Pfizer Healthcare India Private LimitedVisakhapatnam, India1 insp.
Novartis Pharma AGBasel, Switzerland1 insp.
Novartis Pharma Schweizerhalle AgPratteln, Switzerland1 insp.
Novo Nordisk Production Belgium SABrussels, Belgium1 insp.
Co-investigators
Investigators who share inspections with this person.
Darren S Brown3 shared
Junho Pak2 shared
Roger F Zabinski2 shared
Linda Thai2 shared
Binh T Nguyen2 shared
Jeanne M Fringer1 shared
Thuy T Nguyen1 shared
Atul Agrawal1 shared
Thomas J Arista1 shared
Rita K Kabaso1 shared
Full investigator report
Get the verbatim findings behind Yasamin Ameri's 398 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site